|
|
||||||||
The Wadsworth Center, New York State Department of Health, Albany, New York 12201-0509, USA
(RECEIVED August 22, 2006; FINAL REVISION March 27, 2007; ACCEPTED March 27, 2007)
| Abstract |
|---|
|
|
|---|
Keywords: mutations; thymidylate synthase; subunit dissociation; proteolysis; mass spectrometry; peptide identification
| Introduction |
|---|
|
|
|---|
The first indication we had that the TS dimer was not as rigid in solution as would be expected from its observed crystal structure (Montfort et al. 1990) came from the finding that specific inactive mutant TS homodimers, such as C146W and R126E, when mixed together at room temperature yielded an active heterodimer with an activity equivalent to that of the native enzyme (Maley et al. 1995; Saxl et al. 2001). Since only one of the two subunits appears to be active under these conditions, the enzyme possesses the characteristics described for a half-the-sites-of-activity enzyme (Maley et al. 1995). As a consequence of this property we hypothesized that the subunits of the mutant homodimers dissociate in dilute solution and then reform as a more stable heterodimer to restore one of the enzyme's two active sites as described by Saxl et al. (2001) and West et al. (2004). The magnitude of this change is quite striking since the R126E mutation reduces the TS activity of the wild-type enzyme by about 2000-fold (Strop et al. 1997), while the TS activity of C146W mutant is not measurable. The exchange of the R126E mutant subunits with other TS mutant subunits implies that this process is facilitated by subtle differences in conformation, which alter the dynamics of exchange between the subunits of WT-TS and its inactive mutants favoring dissociation to monomers in the latter case. In this article we will present evidence that the dynamics of monomerdimer exchange in dilute solutions of specific TS mutants could make them more susceptible to trypsin digestion relative to WT-TS. However, it cannot be ruled out that some if not most of the mutants are conformationally less compact than WT-TS, which, as a result, are more susceptible to trypsin. These differences are not apparent in the protein of WT-TS crystals, which, at the concentration of protein present, are mainly dimer, an effect that is particularly true in the case of Y94F, whose X-ray structure is almost identical to WT-TS (Roberts et al. 2006). As discussed recently by Volkov et al. (2006) since protein complexes in solution consist of multiple species, the crystal structure might represent only a subpopulation of protein orientations, one that is not the most active form. Such may be the case in the studies to be described in this article.
| Results |
|---|
|
|
|---|
|
|
|
|
|
9.0 greatly enhance the rate of reactivation of TS on mixing the minimally active mutants R126E and Y94A (Saxl et al. 2001). Under the above conditions the restoration of activity was almost instantaneous, particularly at pH 9.0. These findings suggested that the rapid appearance of activity was in part due to a greater concentration of mutant subunits at pH 9.0 than at pH 7.5, which, as a consequence of mass action, interacted to form the active heterodimer. The above proteolysis experiments implied that the subunits are in equilibrium with their respective homodimers or, alternatively, that a conformational difference in the proteins resulting from a specific mutation in the homodimer enabled trypsin to have greater access to specific susceptible regions relative to WT-TS. It is possible that both phenomena are occurring at the same time. To determine if this is the case, we examined the oligomeric state of WT-TS and three of its mutants (R126E, Y94A, and C146W) when exposed to 0.5 M, 1.0 M, and 1.5 M urea, to verify whether monomeric forms of these proteins could be detected by sedimentation velocity in the analytic ultracentrifuge. At a concentration of 0.5 M urea, the peaks showed some broadening relative to those in the absence of urea (Fig. 5), but at 1.0 M urea, a peak corresponding to a monomeric subunit was evident in the sedimentation patterns in addition to the dimer. On increasing the concentration of urea to 1.5 M the peaks for R126E, Y94A, and C146W became quite diffuse, showing both high molecular weight bands and monomer. In contrast it should be noted that the WT-TS dimeric structure was unaffected by 1.5 M urea, as anticipated from its greater stability relative to these mutants, when exposed to trypsin (Fig. 1). The broadness of the bands in 1.5 M urea over a range of high S20,W values is probably due to the aggregation of the monomers to oligomers. These results are consistent with the finding that low urea concentrations enhance the dissociation of the inactive mutants, which then interact with R126E subunits to yield an active heterodimer (Maley et al. 1995; Saxl et al. 2001). For this to occur, the heterodimer must be more stable than the mutant homodimers. It is not obvious how the dissociation enables subunits of one homodimer to associate with another to yield active enzyme, but it is clear that a perturbation of the dimeric state is involved in this process and is supported by the finding that the mutants are hydrolyzed more rapidly by trypsin in the presence of 0.51.5 M urea. Thus, R126E showed less breakdown in the TS region (31 kDa) than Y94F and C146W, but the latter was completely digested by trypsin in 0.5 M urea when measured by SDS-PAGE (data not shown), which again emphasizes the difference in structural stability of these mutants. As expected, WT-TS was hardly affected by trypsin even at 1.5 M urea, where it still retains its dimeric state in contrast to the mutants. It would be fair to state therefore that those mutants that are most affected by urea are the ones most susceptible to trypsin digestion, as expected from the results in Figure 5.
|
|
| Discussion |
|---|
|
|
|---|
|
|
which contains the various specified subunits and dimers with A B being the most stable form based on the measured increase in enzyme activity with time. This assumption is supported by several experiments, which reveal that any condition that perturbs the dimermonomer equilibrium to increase the monomer level results in an increase in the rate of formation of the active heterodimer A B. Thus, low concentrations of urea (1.5 M), ethanol, elevated temperature (37°C), and pH as well as dilution promote A B formation and support this proposal (Maley et al. 1995; Saxl et al. 2001). In contrast, conditions that reduce the formation of monomer, i.e., low temperature (10°C), increased viscosity, or pHs < 7.0, slow the rate of A B formation rather drastically.
However, other observations are not in complete agreement with the monomerdimer proposal as shown in Supplemental Figs. S2 and S3, where sedimentation velocity analyses reveal that although dilution of WT-TS and its mutants to 2 µg/mL or less promotes monomer formation, 5 µg/mL or greater yields mainly dimer. This being the case, most of the TS assays that were performed to measure active heterodimer formation contained levels of protein favoring the presence of dimer predominantly. It is possible though that sufficient amount of nondetectable monomer were interspersed with the dimer to shift the equilibrium to A B formation.
Another conflicting point relates to the varied susceptibility of the TS mutants described in Figure 13 to trypsin digestion, in contrast to the highly resistant WT-TS. These data are not consistent with the X-ray structures of such mutants as R126E (Strop et al. 1997) and Y94F (Roberts et al. 2006), which are almost identical to WT-TS. Being that the crystal structures of WT-TS and Y94F are so alike it is difficult to explain why Y94F is more susceptible to trypsin or why it forms active heterodimers so readily with R126E. It is of interest to note that recent studies using thermal CD titration that measures the temperature at which the protein structure unfolds to 50% (Tm ) revealed that the Tm for Y94F is 46°C, the same as that for WT-TS. This is the same Tm reported for WT-TS using differential scanning calorimetry (Chen et al. 1996), again emphasizing the point that the structural forces holding WT-TS and Y94F together are about the same. One must conclude therefore that for whatever reason, the structure of WT-TS is not identical to the above mutants in solution, at least not in the eyes of trypsin. So how can this dilemma be resolved? One possibility is that the mutants are slightly more dissociated to the monomeric state than WT-TS, with the monomers being more readily proteolyzed than the dimers. However, at the concentrations of protein where the digestions were conducted (1 mg/mL), the major species by far would be dimeric, whether WT-TS or mutant. Another possibility is that there are subtle differences in compactness between the mutants and WT-TS in solution, which would allow trypsin greater access to the former, relative to the latter. Due to the marked alteration in structure that dUMP and folate analogs (Montfort et al. 1990) inflict on E. coli TS, it is presumed that they would have the same effect on the mutants to which they can bind, as seen by the resistance of the mutants in the presence of the substrate analogues (Supplemental Fig. S1).
Additionally it is becoming apparent that although protein structures are usually described as a single structural entity, they in reality exist as a composite of multiple conformations with only small energy differences between them (Gutteridge and Thornton 2005). As discussed by Volkov et al. (2006), protein complexes in solution are dynamic and the crystal structures could represent only a subpopulation of protein orientations. Since these multiple forms are in dynamic equilibrium with one another, it can be proposed similarly that A and B interact to form the lowest and most stable energy state, A B.
While we have come a long way in explaining how proteins behave thermodynamically in solution, there are still many gaps to fill, such as how dimers unfold to monomers and then refold with one another to form homodimers or active heterodimers, as described earlier (Saxl et al. 2001) and in this article. This question may be extended further to the case of how subunits when released from ribosomes during the course of translation interact to form complex oligomeric structures. As we have shown earlier (West et al. 2004), this information can be exploited to inactivate WT-TS with a dominant-negative mutant of TS, an approach that could be useful for purposes of chemotherapy.
| Materials and Methods |
|---|
|
|
|---|
Preparation of WT-TS and TS-mutant proteins
TS was prepared using a high-expression system, which induced the enzyme to 50%60% of the cellular protein of E. coli (Changchien et al. 2000). The enzyme and its mutants were purified to homogeneity in just three steps: sonication of the bacterial pellet, ammonium sulfate precipitation of the induced protein, and purification through a DE-52 anion exchange column as described previously (Changchien et al. 2000). The TS mutants were prepared from the thyA gene with the appropriate oligonucleotides using the Quik-Change procedure of Stratagene and were purified as above for WT-TS. Where necessary, a phenyl-sepharose purification step (Pedersen-Lane 1997) was added after the DE-52 column. If the mutant was inactive, SDS-PAGE was used to determine the least contaminated fractions to be pooled. The enzyme pools were concentrated in an Amicon ultrafiltration apparatus (W.R. Grace & Co.) with a 10-kDa cutoff filter. Proteins were stored as ammonium sulfate pellets at 70°C. Prior to use, the proteins were dissolved in a small volume of a solution containing 50 mM potassium phosphate (pH 7.5), 10% ethylene glycol, 1 mM DTT and then dialyzed against 2 x 250 mL of this buffer overnight. The dialyzed solutions were stored at 20°C.
Measurement of thymidylate synthase activity
The components of the assay solution were modified somewhat (Saxl et al. 2003) from that originally described by Wahba and Friedkin (1961). The kinetic assays were initiated by bringing the final volume of the reaction to 1.0 mL with the addition of 1050 µL of enzyme solution. One unit of TS activity is defined as the amount of enzyme required to synthesize 1 µmol of dTMP/min at 30°C under the conditions of the assay. The protein concentration of TS was calculated from the thyA-TS amino acid sequence (Belfort et al. 1983) using the method of Gill and von Hippel (1989), which provided a molar extinction coefficient of 0.591 x 105 M1cm1 at 280 nm. This value is equivalent to 1.71 A280 units/mg of protein.
Protein digestion
The mutants and WT-TS (620 µg, 10 nmol) were taken up in 1 mL of 400 mM ammonium bicarbonate (pH 8.0) and incubated in the presence of trypsin (w/w 1:100) at 25°C. Aliquots of 50 µL were quenched in 50 µL of SDS-PAGE loading buffer at specified times and subsequently boiled for 5 min. Peptides in aliquots of these digests were electrophoretically separated by 15% SDS-PAGE. For more refined separation of the peptides, precast 4%20% polyacrylamide gels (8 cm x 5.8 cm x 1 mm) from Pierce were used. The running buffer for the gradient gels consisted of Tris-HEPES-SDS (100 mM/100 mM/3 mM).
N-terminal sequencing
To sequence the amino ends of the electrophoretically separated WT and mutant TS tryptic peptides, they were transblotted to a PVDF membrane (Bio-Rad or Perkin Elmer) and the membrane was lightly stained with 0.01% Coomassie blue. The transferred peptides were excised and sequenced with a model 477A protein/peptide sequencer from Applied Biosystems using their Blott Cartridge.
Analytical ultracentrifugation
Sedimentation velocity experiments were performed on a Beckman XLI analytical ultracentrifuge. Experiments were conducted at 25°C using a four-hole titanium AN-60-Ti rotor. The proteins were dialyzed overnight against 2 x 250 mL 50 mM potassium phosphate, 1 mM dithiothreitol (pH 7.5) or 50 mM Tris (pH 9.0) with urea as indicated. The viscosity (
) of the buffers, the density (
) of the buffers, and the partial specific volume (
) of the protein were obtained from SEDNTERP software developed by D. Hayes, T. Laue, and J.S. Philo, which can be downloaded from http://www.jphilo.mailway.com. The partial specific volume of TS calculated from its amino acid content was determined to be 0.736 mL/g at 25°C and 0.734 mL/g at 20°C. A sample volume of 420 µL and a reference volume of 440 µL of the dialysate were loaded in an aluminum two-sector centerpiece cell with quartz windows. Absorption optics set at 230 nm were used to follow the sedimentation of the sample spinning at 50,000 rpm. A single sample was run in each experiment with zero time between scans. The R min was set at 6.0, and the samples were scanned from the earliest time until the boundaries were at the cell bottom to obtain a large number of scans. Care was taken to be at thermal equilibrium before initiation of the centrifuge run. The centrifuge was accelerated directly to the speed of the experiment. The data were analyzed by the c(s) and c(M) methods found in Sedfit (Schuck 2000). The experimentally calculated sedimentation coefficients from the Sedfit program were converted to S20,w by multiplying the apparent five values by 0.92068 (pH 7.5, no urea), 0.95647 (pH 7.5, 0.5 M urea), 0.99965 (pH 7.5, 1 M urea), 1.0448 (pH 7.5, 1.5 M urea), and 0.90968 (pH 9.0, no urea) as described in the above program.
Mass spectrometric peptide analysis
Molecular weights of the peptides resulting from the limited trypsin digests of the TS mutants were obtained by nano-ESI-LC-MS with a Finnigan LCQ-DECA ion trap. The digests were loaded into the nano-LC system via a Protein CapTrap (Michrom Bioresources) and washed with 15% acetonitrile/0.2% formic acid to maximize the proportion of >3-kDa peptides obtained. TS peptides were separated by elution from a C4 column with a reverse phase gradient of 15%80% acetonitrile/0.2% formic acid versus 0.2% formic acid/water ramped over 30 min, and introduced into the ion trap via ionization at the column exit tip. The C4 nano-column, 5 cm x 75 µm i.d., and PicoView nano-electrospray ionization source were from New Objective. TS sequence assignments from peptide masses were determined with the mass search feature of GPMAW (Lighthous Data).
| Footnotes |
|---|
Supplemental material: see www.proteinscience.org
Reprint requests to: Frank Maley, Wadsworth Center, NY State Dept. of Health, Empire State Plaza, Box 509, Albany, NY 12201-0509, USA; e-mail: maley{at}wadsworth.org; fax: (518) 457-7893.
Abbreviations: Amino acid symbols: A, alanine; R, arginine; C, cysteine; E, glutamate, W, tryptophan; Y, tyrosine; CD, circular dichroism; dUMP, 2'-deoxyuridine 5'-monophosphate; H2PteGlu, 7,8-dihydrofolate; DTT, dithiothreitol; DM, double mutant (R126EC146W); FdUMP, 5-fluoro-2'-deoxyuridine 5'-monophosphate; HEPES, (N-[2-hydroxyethyl] piperazine-N'-[2-ethanesulfonic acid]); CH2H4PteGlu, 5,10-methylene-6(R,S) tetrahydrofolate; NMR, nuclear magnetic resonance; PAGE, polyacrylamide gel electrophoresis; PVDF, polyvinylidene difluoride; PDDF, 10-propargyl 5, 8-dideazafolate; SDS, sodium dodecyl sulfate; dTMP, thymidine 5'-monophosphate; TPCK, tosylphenylchloromethylketone, Tris·HCl, Tris (hydroxymethyl)aminomethane-hydrochloride.
Article and publication are at http://www.proteinscience.org/cgi/doi/10.1110/ps.062509807.
| Acknowledgments |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Belfort, M., Maley, G., Pedersen-Lane, J., and Maley, F. 1983. Primary structure of the Escherichia coli Thy A gene product and its thymidylate synthase product. Proc. Natl. Acad. Sci. 80: 49144918.
Boehr, D.D., Dyson, H.J., and Wright, P.E. 2006. An NMR perspective on enzyme dynamics. Chem. Rev. 106: 30553079.[CrossRef][Medline]
Changchien, L.-M., Garibian, A., Frasca, V., Lobo, A., Maley, G.F., and Maley, F. 2000. High level expression of Escherichia coli and Bacillus subtilis thymidylate synthases. Protein Expr. Purif. 19: 265270.[CrossRef][Medline]
Chen, C.H., Davis, R.A., and Maley, F. 1996. Thermodynamic stabilization of nucleotide binding to thymidylate synthase by a potent benzoquinazoline folate analogue inhibitor. Biochemistry 35: 87868793.[CrossRef][Medline]
Eisenmesser, E.Z., Millet, D., Labeikovsky, W., Korzhnev, D.M., Wolf-Martz, M., Bosco, D.A., Skalicky, J.J., Kay, L.E., and Kern, D. 2005. Intrinsic dynamics of an enzyme underlies catalysis. Nature 438: 117121.[CrossRef][Medline]
Galivan, J., Maley, F., and Baugh, C.M. 1977a. Protective effect of pteroylpolyglutamates and phosphate on the proteolytic inactivation of thymidylate synthase. Arch. Biochem. Biophys. 184: 346354.[CrossRef][Medline]
Galivan, J., Noonan, J., and Maley, F. 1977b. Studies on the reactivity of the essential cysteine of thymidylate synthase. Arch. Biochem. Biophys. 184: 336345.[CrossRef][Medline]
Gill, S.C. and von Hippel, P.H. 1989. Calculation of protein extinction coefficients from amino acid sequence data. Anal. Biochem. 182: 319326.[CrossRef][Medline]
Gutteridge, A. and Thornton, J. 2005. Conformational change observed in enzyme crystal structures upon substrate binding. J. Mol. Biol. 346: 2128.[CrossRef][Medline]
Johnson, E.F., Hinz, W., Atreya, C.E., Maley, F., and Anderson, K.S. 2002. Mechanistic characterization of Toxoplasma gondii thymidylate synthase (TS-DHFR)dihydrofolate reductase. Evidence for a TS intermediate and TS half-sites reactivity. J. Biol. Chem. 277: 4312643136.
Kamb, A., Finer-Moore, J.S., and Stroud, R.M. 1992. Cofactor triggers the conformational change in thymidylate synthase: Implications for an ordered binding mechanism. Biochemistry 31: 1287612884.[CrossRef][Medline]
Maley, F., Pedersen-Lane, J., and Changchien, L. 1995. Complete restoration of activity to inactive mutants of Escherichia coli thymidylate synthase: Evidence that E. coli thymidylate synthase is a half-the-sites activity enzyme. Biochemistry 34: 14691474.[CrossRef][Medline]
Mohsen, A.-W.A., Aull, J.L., Payne, D.M., and Daron, H.H. 1995. Ligand-induced conformational changes of thymidylate synthase detected by limited proteolysis. Biochemistry 34: 16691677.[CrossRef][Medline]
Montfort, W.R., Perry, K.M., Fauman, E.B., Finer-Moore, J.S., Maley, G.F., Hardy, L., Maley, F., and Stroud, R.M. 1990. Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and anti-folate. Biochemistry 29: 69646977.[CrossRef][Medline]
Palmer III, A.G. 2004. NMR characterization of the dynamics of biomacromolecules. Chem. Rev. 104: 36233640.[CrossRef][Medline]
Pedersen-Lane, J., Maley, G.F., Chu, E., and Maley, F. 1997. High-level expression of human thymidylate synthase. Protein Expr. Purif. 10: 256262.[CrossRef][Medline]
Roberts, S.A., Hyatt, D.C., Honts, J.E., Changchien, L., Maley, G.F., Maley, F., and Montfort, W.R. 2006. The structure of the Y94F mutant of E. coli thymidylate synthase. Acta Crystallogr. D Biol. Crystallogr. 62: 840843.
Saxl, R.L., Changchien, L.-M., Hardy, L.W., and Maley, F. 2001. Parameters affecting the restoration of activity to inactive mutants of thymidylate synthase via subunit exchange: Further evidence that thymidylate synthase is a half-of-the-sites activity enzyme. Biochemistry 40: 52755282.[Medline]
Saxl, R.L., Reston, J., Nie, Z., Kalman, T.I., and Maley, F. 2003. Modification of Escherichia coli thymidylate synthase at tyrosine-94 by 5-imidazolylpropynyl-2'-deoxyridine 5'-monophosphate. Biochemistry 42: 45444551.[CrossRef][Medline]
Schuck, P. 2000. Size distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and Lamm equation modeling. Biophys. J. 78: 16061619.[Medline]
Spencer, T., Villafranca, J.E., and Appleman, J.R. 1997. Kinetic scheme for thymidylate synthase from Escherichia coli: Determination from measurements of ligand binding, primary and secondary isotope effects, and pre-steady state catalysis. Biochemistry 36: 42124222.[CrossRef][Medline]
Strop, P., Changchien, L.-M., Maley, F., and Montfort, W.R. 1997. Crystal structures of a marginally active thymidylate synthase mutant, Arg126
Glu. Protein Sci. 6: 25042511.[Abstract]
Volkov, A.N., Worrall, J.A.R., Holtzmann, E., and Ubbink, M. 2006. Solution structure and dynamics of the complex between cytochrome c peroxidae determined by paramagnetic NMR. Proc. Natl. Acad. Sci. 103: 1894518950.
Wahba, A.J. and Friedkin, M. 1961. Direct spectrophotometric evidence for the oxidation of tetrahydrofolate during the enzymatic synthesis of thymidylate. J. Biol. Chem. 236: 1112.
West, D.K., Porter, D.C., Saxl, R.L., and Maley, F. 2004. A Trojan horse approach for silencing thymidylate synthase. Biochemistry 43: 91779189.[CrossRef][Medline]
![]()
CiteULike
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |